• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Calculus Capital

Corporate management meetings
Calculus exits Once Upon A Time in management buy-back

Tosca Debt Capital has provided a first lien facility to support the acquisition

  • Exits
  • 31 January 2020
Insulin pens and diabetes medicine
Calculus Capital leads £6m round for Arecor

Albion Capital and Downing Ventures also take part in the funding round

  • Early-stage
  • 10 September 2018
Electronic invoicing software
Calculus invests £2m in CloudTrade

Funding will be used to strengthen the firm's global sales and support the growth of its teams

  • Expansion
  • 27 July 2018
Energy-saving consultants and applications
Calculus Capital invests £3m in Open Energy Markets

UK firm intends to strengthen its sales team and enter the US with the fresh capital

  • Expansion
  • 07 February 2018
Stem cell storage and associated biotechnology
Calculus injects £2.5m into Axol Bioscience

Investment will be used to attract clients and grow the business organically

  • Expansion
  • 16 August 2017
Fibre-optic networks
Calculus invests £2m in Origin Broadband

Deal comes just seven months after the firm invested £3m in the fibre-optic broadband provider

  • Expansion
  • 08 August 2017
Shaving foams and razors
Calculus leads £3.5m funding round for Cornerstone

Online shaving products supplier has secured £8m to date since its launch in 2014

  • Expansion
  • 07 August 2017
The PEF sponsored triathlon
Calculus exits Human Race to Tour de France owner

GP says the sale of its stake in the event organiser has been profitable for its investors

  • Exits
  • 11 October 2016
Safe deposit boxes
Calculus nets 1.8x on Metropolitan Safe Deposits exit

GP exits London-based business four years after investing at 6.32 pence per share

  • Exits
  • 22 September 2016
Biotechnology and medical sciences
Calculus invests £3m in AIM-listed C4X Discovery

Funding round will enable the pharmaceuticals business to fund further drug development

  • PIPEs
  • 07 September 2016
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013